Magnetar Financial’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
GIM
Magnetar Financial's WST Position: Q1 2026 in Review
Magnetar Financial sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 11,918 shares — an estimated $3.28M sold.
Magnetar Financial first reported a position in WST in Q1 2017 and held it in 12 quarters. The position peaked at $10.2M in Q1 2023. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Magnetar Financial reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- Magnetar Financial sold 11,918 West Pharmaceutical shares in Q1 2026, an estimated $3.28M.
- Magnetar Financial first reported a position in West Pharmaceutical in Q1 2017 and held it in 12 quarters.
- Magnetar Financial's West Pharmaceutical position peaked at $10.2M in Q1 2023.
- 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Magnetar Financial's 13F filing for Q1 2026, filed 13 May 2026.